Unknown

Dataset Information

0

Association of Extrarenal Adverse Effects of Posttransplant Immunosuppression With Sex and ABCB1 Haplotypes.


ABSTRACT: Extrarenal adverse effects (AEs) associated with calcineurin inhibitor (CNI) and mycophenolic acid (MPA) occur frequently but are unpredictable posttransplant complications. AEs may result from intracellular CNI accumulation and low activity of P-glycoprotein, encoded by the ABCB1 gene. Since ABCB1 single nucleotide polymorphisms (SNPs) and sex influence P-glycoprotein, we investigated haplotypes and extrarenal AEs. A prospective, cross-sectional study evaluated 149 patients receiving tacrolimus and enteric coated mycophenolate sodium or cyclosporine and mycophenolate mofetil. Immunosuppressive AE assessment determined individual and composite gastrointestinal, neurologic, aesthetic, and cumulative AEs. Lipids were quantitated after 12-hour fast. ABCB1 SNPs: c.1236C>T (rs1128503), c.2677G>T/A (rs2032582), and c.3435C>T (rs1045642) were determined with haplotype associations computed using the THESIAS program, and evaluated by immunosuppression, sex and race using multivariate general linear models. Tacrolimus patients exhibited more frequent and higher gastrointestinal AE scores compared with cyclosporine with association to CTT (P?=?0.018) and sex (P?=?0.01). Aesthetic AE score was 3 times greater for cyclosporine with TTC haplotype (P?=?0.005). Females had higher gastrointestinal (P?=?0.022), aesthetic (P?

SUBMITTER: Venuto RC 

PROVIDER: S-EPMC4635790 | biostudies-literature | 2015 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications


Extrarenal adverse effects (AEs) associated with calcineurin inhibitor (CNI) and mycophenolic acid (MPA) occur frequently but are unpredictable posttransplant complications. AEs may result from intracellular CNI accumulation and low activity of P-glycoprotein, encoded by the ABCB1 gene. Since ABCB1 single nucleotide polymorphisms (SNPs) and sex influence P-glycoprotein, we investigated haplotypes and extrarenal AEs. A prospective, cross-sectional study evaluated 149 patients receiving tacrolimus  ...[more]

Similar Datasets

| S-EPMC5013326 | biostudies-literature
| S-EPMC6379234 | biostudies-literature
| S-EPMC5792297 | biostudies-literature
| S-EPMC8767140 | biostudies-literature
| S-EPMC1876748 | biostudies-literature
| S-EPMC3644159 | biostudies-literature
| S-EPMC6973256 | biostudies-literature
| S-EPMC2689900 | biostudies-other
| S-EPMC3359573 | biostudies-literature
| S-EPMC4426259 | biostudies-literature